NL190923C - Farmaceutisch preparaat omvattende ibuprofen en caffeine. - Google Patents

Farmaceutisch preparaat omvattende ibuprofen en caffeine.

Info

Publication number
NL190923C
NL190923C NL8320239A NL8320239A NL190923C NL 190923 C NL190923 C NL 190923C NL 8320239 A NL8320239 A NL 8320239A NL 8320239 A NL8320239 A NL 8320239A NL 190923 C NL190923 C NL 190923C
Authority
NL
Netherlands
Prior art keywords
caffeine
ibuprofen
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
NL8320239A
Other languages
English (en)
Other versions
NL190923B (nl
NL8320239A (nl
Original Assignee
Richardson Vicks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks filed Critical Richardson Vicks
Publication of NL8320239A publication Critical patent/NL8320239A/nl
Publication of NL190923B publication Critical patent/NL190923B/nl
Application granted granted Critical
Publication of NL190923C publication Critical patent/NL190923C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
NL8320239A 1982-07-22 1983-07-21 Farmaceutisch preparaat omvattende ibuprofen en caffeine. NL190923C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/400,645 US4420483A (en) 1982-07-22 1982-07-22 Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
US40064582 1982-07-22
US8301120 1983-07-21
PCT/US1983/001120 WO1984000487A1 (en) 1982-07-22 1983-07-21 Improved analgesic and anti-inflammatory compositions comprising ibuprofen and method of using same

Publications (3)

Publication Number Publication Date
NL8320239A NL8320239A (nl) 1984-06-01
NL190923B NL190923B (nl) 1994-06-01
NL190923C true NL190923C (nl) 1994-11-01

Family

ID=23584445

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8320239A NL190923C (nl) 1982-07-22 1983-07-21 Farmaceutisch preparaat omvattende ibuprofen en caffeine.

Country Status (16)

Country Link
US (1) US4420483A (nl)
JP (1) JPS59501413A (nl)
AT (1) AT389051B (nl)
AU (1) AU560092B2 (nl)
BE (1) BE897355A (nl)
CA (1) CA1217428A (nl)
CH (1) CH659946A5 (nl)
DE (1) DE3390114T1 (nl)
FR (1) FR2530468B1 (nl)
GB (1) GB2132891B (nl)
IE (1) IE55366B1 (nl)
IT (1) IT1206693B (nl)
NL (1) NL190923C (nl)
SE (1) SE466889B (nl)
WO (1) WO1984000487A1 (nl)
ZA (1) ZA835325B (nl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3390116C2 (de) * 1982-07-22 1994-06-16 Richardson Vicks Inc Verbesserte, Koffein enthaltende, analgetische und antiinflammatorische Mittel
DE3348444C2 (de) * 1982-07-22 1995-02-02 Richardson Vicks Inc Analgetische und antiinflammatorische Mittel
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
CA2144152A1 (en) * 1992-09-29 1994-04-14 Robert T. Sims Ibuprofen-caffine combinations
AU672279B2 (en) * 1992-12-21 1996-09-26 Procter & Gamble Company, The Compositions containing caffeine and S(+)-ibuprofen or S(+)-flurbiprofen or S(+)-ketoprofen
AU676315B2 (en) * 1993-06-30 1997-03-06 Takeda Chemical Industries Ltd. Stabilized solid pharmaceutical preparation and method of producing the same
WO1995007079A1 (en) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
JPH0987174A (ja) * 1995-09-26 1997-03-31 Kobayashi Pharmaceut Co Ltd 鎮痛性および抗炎症性組成物
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US20020177626A1 (en) * 2001-01-19 2002-11-28 Cook Graham D. Treatment of sleep disturbances
JP2003277258A (ja) * 2002-03-20 2003-10-02 Ss Pharmaceut Co Ltd 片頭痛治療剤
US7332525B2 (en) * 2003-01-17 2008-02-19 Castle Erik P Method of treatment of prostate cancer and composition for treatment thereof
US20050065172A1 (en) * 2003-09-23 2005-03-24 Shah Indukumar G. Solid dosage form comprising caffeine
US20090155355A1 (en) * 2007-12-12 2009-06-18 Multi Formulations Ltd. Particles in a capsule
CN107205946A (zh) * 2014-08-28 2017-09-26 赛诺菲-安万特德国有限公司 用于治疗急性牙痛或下颌疼痛的药物组合物
ES2932980T3 (es) * 2014-08-28 2023-01-30 Sanofi Aventis Deutschland Comprimido recubierto con película para el tratamiento del dolor agudo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2559384A1 (de) * 1975-12-31 1977-07-14 Josef Dipl Chem Dr Rer N Klosa Coffein-kombination
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
US4264582A (en) * 1978-07-31 1981-04-28 The Procter & Gamble Company Isobutylphenylacetate anti-inflammatory composition
CS202326B1 (cs) * 1978-10-06 1980-12-31 Miloslav Krsiak Kombinované analgetikum
JPS5697224A (en) * 1979-12-28 1981-08-05 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition

Also Published As

Publication number Publication date
AU1828783A (en) 1984-02-23
ZA835325B (en) 1984-09-26
DE3390114C2 (nl) 1990-07-05
US4420483A (en) 1983-12-13
CA1217428A (en) 1987-02-03
NL190923B (nl) 1994-06-01
FR2530468A1 (fr) 1984-01-27
NL8320239A (nl) 1984-06-01
AU560092B2 (en) 1987-03-26
ATA903883A (de) 1989-03-15
IT1206693B (it) 1989-04-27
SE8401537L (sv) 1984-03-20
DE3390114T1 (de) 1985-01-10
FR2530468B1 (fr) 1987-01-16
WO1984000487A1 (en) 1984-02-16
JPH0124131B2 (nl) 1989-05-10
SE8401537D0 (sv) 1984-03-20
IE831714L (en) 1984-01-22
IT8322172A0 (it) 1983-07-21
CH659946A5 (de) 1987-03-13
SE466889B (sv) 1992-04-27
GB8406703D0 (en) 1984-04-18
BE897355A (fr) 1983-11-14
JPS59501413A (ja) 1984-08-09
GB2132891B (en) 1986-05-08
IE55366B1 (en) 1990-08-29
AT389051B (de) 1989-10-10
GB2132891A (en) 1984-07-18

Similar Documents

Publication Publication Date Title
IT1148238B (it) Dispositivo per la somministrazione di medicamenti in polvere
BR1100036A (pt) Composto e composição farmacêutica
ATE22007T1 (de) Pharmazeutische mischung.
NL190923C (nl) Farmaceutisch preparaat omvattende ibuprofen en caffeine.
MX9203480A (es) Formulaciones medicinales en aereosol.
DK481989A (da) Farmaceutiske formuleringer
IT8322845A0 (it) Cosmetico e suo procedimento di preparazione.
ZA828797B (en) Pharmaceutical formulation
DE3483133D1 (de) Pharmazeutische zusammensetzungen.
DE3485408D1 (de) Pharmazeutische zusammensetzung.
DE3484098D1 (de) Pharmazeutische zusammensetzungen.
NO863029D0 (no) Farmasoeytisk doseringsenhet.
DK345682A (da) Pharmaceutiske expienser
NL188905C (nl) Anthracyclineverbinding en farmaceutisch preparaat.
DK64183D0 (da) Farmaceutisk praeparat samt fremgangsmade til fremstilling deraf
DE3882157T2 (de) Nichtsteroide Antientzündungswirkstoffe enthaltende pharmazeutische Zubereitungen.
IT8248677A0 (it) Formulazioni farmaceutiche
DE3576118D1 (de) Pharmazeutische praeparate.
DE3682960D1 (de) Pharmazeutische praeparate.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
MX5577A (es) Formulacion farmaceutica
FI831687A0 (fi) Farmaceutiska blandningar vilka innehaoller flere aktiva bestaondsdelar
ATE36455T1 (de) Pharmazeutische zusammensetzungen.
FI923371A (fi) En farmaceutisk formulation.
IT1206519B (it) Immino ed amminoacidi acilossichetone sostituiti.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20030721